Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) have received an average rating of “Moderate Buy” from the ten analysts that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating and eight have issued a buy rating on the company. The average […]

Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the fifteen analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and thirteen have assigned a buy rating […]

CDW Corporation (NASDAQ:CDW – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. […]